Alzheimer's Foundation of America Comments on the Proposed $350 Million Increase to the National Institute on Aging's Funding

The Alzheimer’s Foundation of America (AFA) has issued a statement in support of the proposed $350 million increase for Alzheimer’s disease clinical research at the National Institute on Aging (NIA), the lead federal institute researching Alzheimer’s disease. Additionally, they support an overall $2 billion increase at the National Institutes of Health (NIH) in upcoming fiscal year.
According to the press release, the AFA’s president and chief executive office Charles J. Fuschillo, Jr. stated:

“The Alzheimer’s Foundation of America (AFA) is grateful to Congressional leaders for recognizing the need to make Alzheimer’s disease a national priority and urges Congressional representatives to approve this budget package.
“As our nation ages, the impact of Alzheimer’s disease will be more profound and more families will face the effects of this debilitating brain disorder, which currently affects more than 5 million Americans. This proposed funding increase is a significant step forward in investing in promising research toward a cure. At the same time, funding for Alzheimer’s disease research still lags far behind other disease states. Alzheimer’s stakeholders and our champions in Congress, therefore, must remain vigilant and continue to build upon this momentum. With continued progress, it is possible to achieve the goals of National Plan to Address Alzheimer’s Disease and to find a cure or meaningful treatment by 2025.”

Click here to read the full press release.